Related Experiment Video

Updated: May 5, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

8.8K

Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast

Pinghua Hu1, Qin Huang, Zhihua Li

  • 1Jiangxi Breast Center Third Hospital of Nanchang, Nanchang, 33009, China.

Molecular Biology Reports
|November 21, 2013
PubMed

Insights

MAP3K1 (Mitogen-activated protein kinase kinase kinase 1) is overexpressed in breast cancer. Silencing MAP3K1 enhances paclitaxel

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) plays a role in cellular signaling pathways.
  • Aberrant MAP3K1 expression is implicated in various cancers, including breast cancer.

Purpose of the Study:

  • To compare MAP3K1 expression levels in normal mammary cells versus breast cancer cells.
  • To investigate the therapeutic potential of targeting MAP3K1 in paclitaxel-treated breast cancer cells.

Main Methods:

  • Western blotting to quantify MAP3K1 protein levels.
  • Real-time PCR to assess gene silencing efficacy.
  • MTT assay for cell proliferation analysis.
  • Flow cytometry for cell cycle analysis.

Main Results:

  • MAP3K1 protein expression was significantly higher in breast cancer cells compared to normal mammary cells.
  • MAP3K1 siRNA transfection effectively reduced MAP3K1 expression.
  • Silencing MAP3K1 potentiated paclitaxel's effects by inhibiting proliferation and inducing cell cycle arrest.

Conclusions:

  • Elevated MAP3K1 expression is a feature of breast cancer.
  • Targeting MAP3K1 with small RNA interference can enhance the efficacy of paclitaxel chemotherapy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

28.0K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K